ResearcherMayo ClinicActive in the last 2 years
Kayla C. LaRue-Nolan
Matched on ORCID iD 0000-0002-7781-8674; OpenAlex author ID A5099246034. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 5
- Nuclear VAV1 increases GLI1-dependent transcription in pancreatic cancer cells. Co-author DOI 10.1016/j.jbc.2025.110988↗
- A Novel Emerin/Nesprin-3 Interaction Mediates Nuclear Size Changes Induced by Oncogenic KRAS in Pancreatic Cancer Cells. Co-author DOI 10.1080/10985549.2026.2670710↗
- Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. Co-author DOI 10.1172/jci.insight.187799↗
- Insights into the mechanisms driven by H3K4 KMTs in pancreatic cancer. Co-author DOI 10.1042/bcj20230374↗
- EGFR Reloaded: Finding New Ways to Shape Pancreatic Cancer Epigenome. Co-author DOI 10.1016/j.jcmgh.2023.02.003↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Martín E. Fernández-Zapico · 5 shared papers, 2023–2026 · strength 1.42
- Paper EGFR Reloaded: Finding New Ways to Shape Pancreatic Cancer Epigenome. DOI 10.1016/j.jcmgh.2023.02.003↗
- Paper Nuclear VAV1 increases GLI1-dependent transcription in pancreatic cancer cells. DOI 10.1016/j.jbc.2025.110988↗
- Paper Insights into the mechanisms driven by H3K4 KMTs in pancreatic cancer. DOI 10.1042/bcj20230374↗
- Brooke R Tader · 3 shared papers, 2025–2026 · strength 0.75
- Paper Nuclear VAV1 increases GLI1-dependent transcription in pancreatic cancer cells. DOI 10.1016/j.jbc.2025.110988↗
- Paper A Novel Emerin/Nesprin-3 Interaction Mediates Nuclear Size Changes Induced by Oncogenic KRAS in Pancreatic Cancer Cells. DOI 10.1080/10985549.2026.2670710↗
- Paper Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. DOI 10.1172/jci.insight.187799↗
- Renzo Emanuel Vera · 2 shared papers, 2025–2026 · strength 0.46
- Luis F. Flores · 2 shared papers, 2025–2026 · strength 0.46
- Daniel D. Billadeau · 1 shared paper, 2026 · strength 0.29
- Glancis L. Raja Arul · 1 shared paper, 2024 · strength 0.28
- Jiaqi Shi · 1 shared paper, 2024 · strength 0.28
- Ezequiel J. Tolosa · 1 shared paper, 2025 · strength 0.19
- Aleksey V. Matveyenko · 1 shared paper, 2025 · strength 0.19
- Catherine E. Hagen · 1 shared paper, 2025 · strength 0.19
- Rondell Patrell Graham · 1 shared paper, 2025 · strength 0.19
- David R Pease · 1 shared paper, 2025 · strength 0.19
- Ryan Michael Carr · 1 shared paper, 2025 · strength 0.19
- Christopher L. Pin · 1 shared paper, 2025 · strength 0.19
- David W. Dawson · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.